Full-cycle Health Management of Multiple Myeloma.
10.3881/j.issn.1000-503X.13467
- Author:
Jia-Yu DUAN
1
;
Jian CUI
1
;
Wen-Jiao TANG
1
;
Zhong-Qing ZOU
1
;
Li ZHANG
1
Author Information
1. Institute of Hematology,Department of Hematology,West China Hospital,Sichuan University,Chengdu 610041,China.
- Publication Type:Review
- Keywords:
full-cycle management;
health management;
monoclonal gammopathy of undetermined significance;
multiple myeloma;
smoldering multiple myeloma
- MeSH:
Humans;
Immunotherapy;
Multiple Myeloma/therapy*;
Prognosis
- From:
Acta Academiae Medicinae Sinicae
2022;44(4):673-677
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma is a hematologic tumor characterized by clonal proliferation of plasma cells.The development of novel agents and immunotherapy have substantially improved the prognosis of multiple myeloma,with an expectable median survival beyond ten years.Therefore,there is an urgent need to improve the management of this disease.Health management is effective in controlling chronic diseases and full-cycle management should be implemented from the early to the end stage of the disease.Implanting the full-cycle concept into the health management of multiple myeloma will guide and standardize the advances in this field.This review focuses on the full-cycle concept of multiple myeloma and the corresponding application of health management at each stage of the cycle.
